About Kevin Li
Kevin Li is a director at Allotera Therapeutics.
Kevin Li first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Li in the role, so the role may have started earlier or lasted longer.
Allotera Therapeutics, Inc.
Director
2021 – 2026 · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
Key Colleagues at Startups
The people Kevin Li works with at each company, as listed on that company's latest Form D.
Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
Drew Dennison
Director
NM
Natalie Mount
Director
ND
Niall O'Donnell
Director
Kumar Srinivasan
President & Chief Executive Officer, director
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
PK
Peter Kiener
Chair
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
Bali Muralidhar
Director